Stock Events

Stock Events

Nouveau Life Pharmaceuticals 

$0.000001
6
-$0.00-99% Thursday 18:56

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0001
52W Low
0.000001
Volume
100,000
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31MarExpected
Q1 2007
Q3 2007
Q4 2007
Q1 2008
Q1 2011
Q4 2011
-0
-0
-0
0
Expected EPS
0
Actual EPS
-0.0002

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company that competes in various therapeutic areas, potentially overlapping with NOUV's product lines.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the pharmaceutical sector with a broad range of products that could compete with NOUV's offerings.
Merck
MRK
Mkt Cap366B
Merck is a leading pharmaceutical company with a diverse portfolio that may include competitive products in the same categories as NOUV.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, with its strong emphasis on research and development in pharmaceuticals, could have overlapping interests with NOUV's market.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences focuses on life-saving medicines, potentially in direct competition with any of NOUV's therapeutic areas.
AMGEN
AMGN
Mkt Cap233.78B
Amgen, a biotechnology company, develops innovative medicines that could compete with NOUV's pharmaceutical products.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb, with its wide range of prescription medicines, may offer products that compete with NOUV's portfolio.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company with a strong pharmaceutical division that could directly compete with NOUV.
Sanofi
SNY
Mkt Cap107.39B
Sanofi, a multinational pharmaceutical company, produces a variety of medicines that could be in competition with NOUV.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG, with its focus on pharmaceuticals and diagnostics, is a potential competitor in the same therapeutic areas as NOUV.

About

Nouveau Life Pharmaceuticals, Inc. (NOUV) is a company in its developmental stage, primarily focused on crafting nutraceutical products. It offers both natural health solutions and pharmaceutical drugs. The entity, which began operations in 1998, was previously known as Hybrid Fuels, Inc. before adopting its current designation in May 2012. Based in Ft. Lauderdale, Florida, Nouveau Life Pharmaceuticals, Inc. functions as an affiliate of EMG Marketing Solutions, Inc.
Show more...
CEO
Brian Shibley
Country
United States
ISIN
US66979K1034

Listings

OTC Link
US
NOUV

0 Comments

Share your thoughts

FAQ

What is Nouveau Life Pharmaceuticals stock price today?▼
The current price of NOUV is $0.00 USD — it has decreased by -99% in the past 24 hours. Watch Nouveau Life Pharmaceuticals stock price performance more closely on the chart.
What is Nouveau Life Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Nouveau Life Pharmaceuticals stocks are traded under the ticker NOUV.
Is Nouveau Life Pharmaceuticals stock price growing?▼
NOUV stock has fallen by -99% compared to the previous week, the month change is a -99% fall, over the last year Nouveau Life Pharmaceuticals has showed a -99% decrease.
What were Nouveau Life Pharmaceuticals earnings last quarter?▼
NOUV earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
In which sector is Nouveau Life Pharmaceuticals located?▼
Nouveau Life Pharmaceuticals operates in the Health & Wellness sector.
When did Nouveau Life Pharmaceuticals complete a stock split?▼
Nouveau Life Pharmaceuticals has not had any recent stock splits.
Where is Nouveau Life Pharmaceuticals headquartered?▼
Nouveau Life Pharmaceuticals is headquartered in Los Angeles, United States.